Yanrong Qian
Overview
Explore the profile of Yanrong Qian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
993
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang J, Xie Y, Zhu G, Qian Y, Sun Q, Li H, et al.
Biomaterials
. 2025 Mar;
319:123207.
PMID: 40037207
As one of the key tools of biocatalysis, natural enzymes have received extensive attention due to their unique activity. However, the non-selective catalysis and early leakage induced by delivery dependency...
2.
Zhu G, Xie Y, Wang J, Wang M, Qian Y, Sun Q, et al.
Adv Mater
. 2024 Sep;
36(45):e2409066.
PMID: 39285820
The overexpression of polyamines in tumor cells contributes to the establishment of immunosuppressive microenvironment and facilitates tumor growth. Here, it have ingeniously designed multifunctional copper-piceatannol/HA nanopills (Cu-Pic/HA NPs) that effectively...
3.
Xu W, Qian Y, Qiao L, Li L, Xie Y, Sun Q, et al.
ACS Appl Mater Interfaces
. 2024 May;
16(20):26590-26603.
PMID: 38742307
Photodynamic therapy (PDT) based on upconversion nanoparticles (UCNPs) has been widely used in the treatment of a variety of tumors. Compared with other therapeutic methods, this treatment has the advantages...
4.
Qian Y, Chen W, Wang M, Xie Y, Qiao L, Sun Q, et al.
Small Methods
. 2023 Dec;
8(7):e2301231.
PMID: 38126694
Despite significant breakthroughs in immunotherapy, the limitations of inadequate immune stimulation and stubborn immune resistance continue to present opportunities and challenges. Therefore, a two-pronged approach, encompassing the activation of immunogenic...
5.
Xie Y, Wang M, Qiao L, Qian Y, Xu W, Sun Q, et al.
Small Methods
. 2023 Oct;
8(3):e2300945.
PMID: 37906051
Traditionally referred to as "metabolic junk", lactate has now been recognized as essential "energy currency" and crucial "messenger" that contributes to tumor evolution, immunosuppression, etc., thus presenting a promising strategy...
6.
Qiao L, Zhu G, Jiang T, Qian Y, Sun Q, Zhao G, et al.
Adv Mater
. 2023 Oct;
36(8):e2308241.
PMID: 37820717
Activating the strong immune system is a key initiative to counteract dormant tumors and prevent recurrence. Herein, self-destructive and multienzymatically active copper-quinone-GOx nanoparticles (abbreviated as CQG NPs) have been designed...
7.
Qian Y, Wang M, Xie Y, Sun Q, Gao M, Li C
Adv Healthc Mater
. 2023 Aug;
12(32):e2301728.
PMID: 37602576
Notwithstanding that immunotherapy has made eminent clinical breakthroughs, activating the immunogenicity and breaking the immunosuppressive tumor microenvironment (ITME) remains tempting yet challenging. Herein, a customized-designed immunostimulant is engineered for attenuating...
8.
Xie Y, Wang M, Qian Y, Li L, Sun Q, Gao M, et al.
Small
. 2023 Jul;
19(44):e2303596.
PMID: 37394715
Breaking immunosuppressive tumor microenvironment (TME) has unique effects on inhibiting tumor growth and recurrence. Here, an endoplasmic reticulum (ER) targeted PdPtCu nanozyme (PNBCT ) is prepared to boost immunotherapy. First,...
9.
Mora-Criollo P, Basu R, Qian Y, Funk K, Bell S, Young J, et al.
FEBS Open Bio
. 2023 May;
13(7):1346-1356.
PMID: 37163287
Chagas disease (CD) is one of the most devasting parasitic diseases in the Americas, affecting 7-8 million people worldwide. In vitro and in vivo experiments have demonstrated that growth hormone...
10.
Song J, Qian Y, Evers M, Nielsen C, Chen X
Int J Mol Sci
. 2022 Dec;
23(23).
PMID: 36499099
Cancer stem cells (CSCs) are closely associated with metastasis and epithelial mesenchymal transition (EMT). We previously reported that extracellular ATP (eATP) induces and regulates EMT in cancer cells. We recently...